{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T20:53:59Z","timestamp":1763499239838},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1051584"],"award-info":[{"award-number":["GNT1051584"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP1093891"],"award-info":[{"award-number":["DP1093891"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ARC Future Fellowship","award":["FT120100779"],"award-info":[{"award-number":["FT120100779"]}]},{"name":"NHMRC Career Development Fellowship","award":["GNT1023526"],"award-info":[{"award-number":["GNT1023526"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.anaerobe.2015.05.001","type":"journal-article","created":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T06:39:13Z","timestamp":1430635153000},"page":"80-83","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia"],"prefix":"10.1016","volume":"34","author":[{"given":"Kate E.","family":"Mackin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briony","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Kotsanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin P.","family":"Howden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen P.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony M.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas V.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian I.","family":"Rood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant A.","family":"Jenkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dena","family":"Lyras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2015.05.001_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid1205.051064","article-title":"Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003","volume":"12","author":"McDonald","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4161\/gmic.2.3.16333","article-title":"The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection","volume":"2","author":"Reeves","year":"2011","journal-title":"Gut. Microbes"},{"key":"10.1016\/j.anaerobe.2015.05.001_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/fmb.10.169","article-title":"TcdB or not TcdB: a tale of two Clostridium difficile toxins","volume":"6","author":"Carter","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib4","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/JCM.36.8.2240-2247.1998","article-title":"A\u00a0novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates","volume":"36","author":"Rupnik","year":"1998","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib5","doi-asserted-by":"crossref","first-page":"e1000626","DOI":"10.1371\/journal.ppat.1000626","article-title":"Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria","volume":"5","author":"Schwan","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib6","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A\u00a0predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","author":"Rupnik","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5694\/j.1326-5377.2011.tb03012.x","article-title":"Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia","volume":"194","author":"Richards","year":"2011","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/592257","article-title":"Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078","volume":"47","author":"Goorhuis","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib10","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1099\/mic.0.051953-0","article-title":"Genetic markers for Clostridium difficile lineages linked to hypervirulence","volume":"157","author":"Knetsch","year":"2011","journal-title":"Microbiology"},{"key":"10.1016\/j.anaerobe.2015.05.001_bib11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/519181","article-title":"Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile","volume":"28","author":"Drudy","year":"2007","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10096-001-0658-0","article-title":"E\u00a0test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid","volume":"21","author":"Leroi","year":"2002","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-1119(96)00398-8","article-title":"Definition of the single integration site of the pathogenicity locus in Clostridium difficile","volume":"181","author":"Braun","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.anaerobe.2015.05.001_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1574-6968.2000.tb09122.x","article-title":"Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile","volume":"186","author":"Stubbs","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib15","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/JCM.40.9.3470-3475.2002","article-title":"Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates","volume":"40","author":"Spigaglia","year":"2002","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib16","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1469-0691.2007.01824.x","article-title":"Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates","volume":"13","author":"Barbut","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/JCM.37.2.461-463.1999","article-title":"PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes","volume":"37","author":"Stubbs","year":"1999","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","article-title":"Clostridium difficile infection in Europe: a hospital-based survey","volume":"377","author":"Bauer","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.anaerobe.2015.05.001_bib19","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/cid\/cis786","article-title":"Clostridium difficile ribotype does not predict severe infection","volume":"55","author":"Walk","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/cid\/cis614","article-title":"Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England","volume":"55","author":"Wilcox","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib21","series-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard \u2013 Seventh Edition","author":"Clinical and Laboratory Standards Institute","year":"2007"},{"key":"10.1016\/j.anaerobe.2015.05.001_bib22","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1099\/00221287-147-10-2717","article-title":"Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile","volume":"147","author":"Farrow","year":"2001","journal-title":"Microbiology"},{"key":"10.1016\/j.anaerobe.2015.05.001_bib23","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1128\/AAC.40.11.2500","article-title":"Genetic organization and distribution of tetracycline resistance determinants in Clostridium perfringens","volume":"40","author":"Lyras","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/AAC.00957-07","article-title":"Tetracycline resistance gene tet(W) in the pathogenic bacterium Clostridium difficile","volume":"52","author":"Spigaglia","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib25","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1128\/JB.182.13.3775-3783.2000","article-title":"Characterization of the ends and target sites of the novel conjugative transposon Tn5397 from Clostridium difficile: excision and circularization is mediated by the large resolvase, TndX","volume":"182","author":"Wang","year":"2000","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib26","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1128\/AAC.46.11.3418-3421.2002","article-title":"gyrA and gyrB mutations are implicated in cross-resistance to ciprofloxacin and moxifloxacin in Clostridium difficile","volume":"46","author":"Dridi","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5694\/j.1326-5377.2011.tb03006.x","article-title":"Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection","volume":"194","author":"Cheng","year":"2011","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib28","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1592\/phco.30.12.1266","article-title":"Alternative therapies for Clostridium difficile infections","volume":"30","author":"Venuto","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.anaerobe.2015.05.001_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/jac\/dkh278","article-title":"A\u00a0double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea","volume":"54","author":"Wullt","year":"2004","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0016-5085(85)90206-9","article-title":"Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin","volume":"89","author":"Young","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anaerobe.2015.05.001_bib31","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1128\/AAC.47.7.2334-2338.2003","article-title":"In\u00a0vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria","volume":"47","author":"Citron","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib32","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01283-06","article-title":"Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile","volume":"51","author":"Noren","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jac\/dkt477","article-title":"Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis","volume":"69","author":"Slimings","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib34","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1099\/jmm.0.057117-0","article-title":"Clostridium difficile erm(B)-containing elements and the burden on the in\u00a0vitro fitness","volume":"62","author":"Wasels","year":"2013","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib35","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/JCM.01171-10","article-title":"Relatedness of human and animal Clostridium difficile PCR ribotype 078 isolates determined on the basis of multilocus variable-number tandem-repeat analysis and tetracycline resistance","volume":"48","author":"Bakker","year":"2010","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fmicb.2011.00203","article-title":"Acquired antibiotic resistance genes: an overview","volume":"2","author":"van Hoek","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1099\/jmm.0.47738-0","article-title":"Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C.\u00a0difficile infections in Europe","volume":"57","author":"Spigaglia","year":"2008","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5694\/mja13.11153","article-title":"Increasing incidence of Clostridium difficile infection, Australia, 2011\u20132012","volume":"200","author":"Slimings","year":"2014","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.anaerobe.2015.05.001_bib39","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/cid\/ciu203","article-title":"Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain","volume":"58","author":"Lim","year":"2014","journal-title":"Clin. Infect. Dis."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996415300172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996415300172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T19:11:06Z","timestamp":1598987466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996415300172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":39,"alternative-id":["S1075996415300172"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2015.05.001","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2015.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}